[{"address1": "150 West 4th Ave", "city": "Vancouver", "state": "BC", "zip": "V5Y 1G6", "country": "Canada", "phone": "604 559 9005", "website": "https://www.abcellera.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.", "fullTimeEmployees": 596, "companyOfficers": [{"maxAge": 1, "name": "Dr. Carl L.G. Hansen Ph.D.", "age": 51, "title": "CEO, President & Chairperson", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 746836, "exercisedValue": 210706, "unexercisedValue": 2408685}, {"maxAge": 1, "name": "Mr. Andrew  Booth M.B.A.", "age": 52, "title": "Chief Financial Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 671720, "exercisedValue": 0, "unexercisedValue": 12299500}, {"maxAge": 1, "name": "Dr. Veronique  Lecault Ph.D.", "age": 41, "title": "CTO & Director", "yearBorn": 1984, "fiscalYear": 2024, "totalPay": 667706, "exercisedValue": 230210, "unexercisedValue": 1260000}, {"maxAge": 1, "name": "Mr. Tryn T. Stimart Esq., J.D., M.Sc.", "age": 56, "title": "Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 685080, "exercisedValue": 0, "unexercisedValue": 3502170}, {"maxAge": 1, "name": "Mr. Andrew  Knowles M.Sc.", "title": "VP of Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Marcie  Thiessen CPA, CGA", "title": "Senior Director of Finance & Accounting", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Martin  Hogan M.Sc.", "title": "Senior Director of Strategic Finance & IR", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tiffany  Chiu B.Sc., Ph.D.", "title": "Vice President of Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Graham  Craig M.Sc.", "title": "Director of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Caitlin  Webster CIPD, M.Sc.", "title": "Director of Talent Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 5, "overallRisk": 8, "governanceEpochDate": 1769904000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.78, "open": 2.93, "dayLow": 2.8801, "dayHigh": 3.17, "regularMarketPreviousClose": 2.78, "regularMarketOpen": 2.93, "regularMarketDayLow": 2.8801, "regularMarketDayHigh": 3.17, "payoutRatio": 0.0, "beta": 0.843, "forwardPE": -4.5797105, "volume": 5379169, "regularMarketVolume": 5379169, "averageVolume": 4388301, "averageVolume10days": 5169050, "averageDailyVolume10Day": 5169050, "bid": 3.11, "ask": 3.2, "bidSize": 4, "askSize": 4, "marketCap": 945898752, "fiftyTwoWeekLow": 1.891, "fiftyTwoWeekHigh": 6.515, "allTimeHigh": 71.91, "allTimeLow": 1.891, "priceToSalesTrailing12Months": 26.777035, "fiftyDayAverage": 3.7546, "twoHundredDayAverage": 3.9273, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 592444736, "profitMargins": 0.0, "floatShares": 204326104, "sharesOutstanding": 299335048, "sharesShort": 47000042, "sharesShortPriorMonth": 50505133, "sharesShortPreviousMonthDate": 1765756800, "dateShortInterest": 1768435200, "sharesPercentSharesOut": 0.157, "heldPercentInsiders": 0.22969, "heldPercentInstitutions": 0.33001998, "shortRatio": 10.95, "shortPercentOfFloat": 0.2037, "impliedSharesOutstanding": 299335048, "bookValue": 3.224, "priceToBook": 0.9801489, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -171676992, "trailingEps": -0.57, "forwardEps": -0.69, "enterpriseToRevenue": 16.771, "enterpriseToEbitda": -2.546, "52WeekChange": -0.07947022, "SandP52WeekChange": 0.120657206, "quoteType": "EQUITY", "currentPrice": 3.16, "targetHighPrice": 16.0, "targetLowPrice": 7.0, "targetMeanPrice": 9.83333, "targetMedianPrice": 9.5, "recommendationMean": 1.375, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 495672000, "totalCashPerShare": 1.656, "ebitda": -232664000, "totalDebt": 142218000, "quickRatio": 8.485, "currentRatio": 10.103, "totalRevenue": 35325000, "debtToEquity": 14.752, "revenuePerShare": 0.119, "returnOnAssets": -0.10426, "returnOnEquity": -0.16814, "grossProfits": -147487008, "freeCashflow": -241470496, "operatingCashflow": -104552000, "revenueGrowth": 0.376, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -8.51792, "financialCurrency": "USD", "symbol": "ABCL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1607697000000, "postMarketChangePercent": 1.9050624, "postMarketPrice": 3.2202, "postMarketChange": 0.060199976, "regularMarketChange": 0.38, "regularMarketDayRange": "2.8801 - 3.17", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 4388301, "fiftyTwoWeekLowChange": 1.269, "fiftyTwoWeekLowChangePercent": 0.6710735, "fiftyTwoWeekRange": "1.891 - 6.515", "fiftyTwoWeekHighChange": -3.3549998, "fiftyTwoWeekHighChangePercent": -0.5149654, "fiftyTwoWeekChangePercent": -7.9470215, "earningsTimestamp": 1771966800, "earningsTimestampStart": 1771966800, "earningsTimestampEnd": 1771966800, "corporateActions": [], "postMarketTime": 1770425548, "regularMarketTime": 1770411602, "exchange": "NMS", "messageBoardId": "finmb_280568380", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "earningsCallTimestampStart": 1771970400, "earningsCallTimestampEnd": 1771970400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.57, "epsForward": -0.69, "epsCurrentYear": -0.6525, "priceEpsCurrentYear": -4.842912, "fiftyDayAverageChange": -0.59459996, "fiftyDayAverageChangePercent": -0.15836573, "twoHundredDayAverageChange": -0.7672999, "twoHundredDayAverageChangePercent": -0.19537593, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-12-11", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": 13.6691, "regularMarketPrice": 3.16, "shortName": "AbCellera Biologics Inc.", "longName": "AbCellera Biologics Inc.", "displayName": "AbCellera Biologics", "trailingPegRatio": null, "__fetch_time": "2026-02-07"}]